MarketPeel
Insider Trading Intelligence
TO

Thomas V. O'halloran

MNPR
10% OWNER · MONOPAR THERAPEUTICS · CIK 0001727481
FILING MIX · LIFETIME0%/100%
BUYS
0
SELLS
7
TOTAL VALUE
$38.00M
COMPANIES
1
ACTIVE SINCE
Feb 2021
HOLDINGS NOW
272,026
AVG SELL PX
$53.63
TRADE KIND
SHOWING 7 / 7
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
7 backtested trades · 8 horizons · 3 pendingHow are these numbers computed? →
Forward-return performance of every backtestable P/S trade by Thomas V. O'halloran, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d7+85.71%-14.73%-0.24%-14.49%-20.76%
14d7+85.71%-16.83%-2.25%-14.57%-28.14%
30d7+71.43%-16.16%+1.02%-17.18%-29.16%
60d7+85.71%-36.03%+4.95%-40.98%-57.12%
90d7+100.00%-39.00%+4.85%-43.85%-55.42%
180d7+85.71%-27.23%+12.42%-39.65%-66.97%
1y7(1 pending)+83.33%-52.96%+14.56%-67.52%-86.41%
2y7(2 pending)+100.00%-65.19%+7.55%-72.74%-72.74%
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
MNPR · 272,026 shares · as of Sep 24, 2025
0205,564411,128616,691822,2552022202320242025SHARES HELD
Trading cadence · quarterly flow
BUY SELL
2021
2021
2021
2021
2022
2022
2022
2022
2023
2023
2023
2023
2024
2024
2024
2024
2025
2025
2025
FLOW · 0 buys / 7 sellsCOVERAGE · 19 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
MNPR
MONOPAR THERAPEUTICS
SALE
550,229$63.61$35.00M272,026Sep 24, 2025Sep 26, 2025View →
MNPR
MONOPAR THERAPEUTICS
SALE
33,334$35.00$1.17M822,255Apr 2, 2025Apr 4, 2025View →
MNPR
MONOPAR THERAPEUTICS
SALE
16,384$16.44$269.4K178,596Feb 11, 2021Feb 16, 2021View →
MNPR
MONOPAR THERAPEUTICS
SALE
29,996$15.12$453.5K194,980Feb 11, 2021Feb 16, 2021View →
MNPR
MONOPAR THERAPEUTICS
SALE
24,224$14.09$341.3K224,976Feb 11, 2021Feb 16, 2021View →
MNPR
MONOPAR THERAPEUTICS
SALE
42,467$13.30$564.8K249,200Feb 11, 2021Feb 16, 2021View →
MNPR
MONOPAR THERAPEUTICS
SALE
11,929$16.90$201.6K166,667Feb 11, 2021Feb 16, 2021View →
Other insiders · MNPR
Loading peer insiders…
About this filer
CIK 0001727481
ROLE
10% Owner
PRIMARY
MNPR
COMPANIES
1
ACTIVE SINCE
Feb 2021
MARKETPEEL · /INSIDER/0001727481DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback